Management of Autosomal Dominant Polycystic Kidney Disease (ADPKD) During Pregnancy: Risks and Challenges
Authors:
Open Access
- 1 May 2020
- journal article
- review article
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 12, 409-422
Abstract
Autosomal dominant polycystic kidney disease (ADPKD) affects up to 1 in 1000 people. The disease is characterized by the progressive development of cysts throughout the renal parenchyma due to inherited pathogenic variants in genes including PKD1 or PKD2 and eventually leads to gradual loss of renal function, along with manifestations in other organ systems such as hepatic cysts and intracranial aneurysms. ADPKD management has advanced considerably in recent years due to genetic testing availability, pre-implantation genetic diagnosis technology and new therapeutic agents. Renal disease in pregnancy is recognised as an important risk factor for adverse maternal and fetal outcome. Women with ADPKD and health professionals face multiple challenges in optimising outcomes during the pre-pregnancy, pregnancy and post-partum periods.Keywords
This publication has 88 references indexed in Scilit:
- Type of PKD1 Mutation Influences Renal Outcome in ADPKDJournal of the American Society of Nephrology, 2013
- Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney DiseaseNew England Journal of Medicine, 2012
- Pregnancy in CKD: whom should we follow and why?Nephrology Dialysis Transplantation, 2012
- Nonclinical Pharmacokinetics of a New Nonpeptide V2 Receptor Antagonist, TolvaptanCardiovascular Drugs and Therapy, 2011
- Hydronephrosis in autosomal dominant polycystic kidney diseaseKidney International, 2009
- Cyst Infections in Patients with Autosomal Dominant Polycystic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2009
- The Risk of Aneurysmal Subarachnoid Hemorrhage During Pregnancy, Delivery, and the Puerperium in the Utrecht PopulationStroke, 2009
- Volume Progression in Polycystic Kidney DiseaseNew England Journal of Medicine, 2006
- Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney diseaseHepatology, 1997
- Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney diseaseKidney International, 1992